Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus

被引:15
作者
Karakitsos, Dimitrios
De Groot, Eric
Patrianakos, Alexandros P.
Parthenakis, Frangiscos
Boletis, John
Karabinis, Andreas
Kyriazis, John
Vardas, Panos
Daphnis, Eugene
机构
[1] Heraklion Univ Hosp, Dept Nephrol, GR-71110 Iraklion, Crete, Greece
[2] Heraklion Univ Hosp, Dept Cardiol, GR-71110 Iraklion, Crete, Greece
[3] Gen State Hosp, Intens Care Unit, Athens, Greece
[4] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Laiko Univ Hosp, Renal Transplantat Unit, Athens, Greece
[6] Gen Hosp Chios, Dialysis Unit, Chios, Greece
关键词
end-stage renal disease; diabetes mellitus; adiponectin; cardiovascular remodeling;
D O I
10.1159/000094403
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives and Methods: Altered plasma high-sensitivity C-reactive protein (hs-CRP) and adiponectin (ADP) may contribute to increased vascular inflammation and accelerated atherosclerosis in patients with end-stage renal disease (ESRD) and co-morbid diabetes. Common carotid artery intima-media thickness (CCA-IMT) and atherosclerotic plaque occurrence, left-ventricular mass index (LVMI), and pulse wave velocity of the proximal aorta (PWVr) were determined by ultrasound imaging in 120 ESRD (55 diabetic) patients, and 83 age-, sex-, and blood pressure-matched controls. Also, plasma levels of ADP and hs-CRP were determined and their relationships with the above cardiovascular alterations were analyzed. Results: LVMI, PWVr, CCA-IMT and atherosclerotic plaque occurrence were all increased in ESRD patients compared to controls (all p < 0.001). LVMl (p < 0.05), PWVr (p < 0.001), CCA-IMT (p < 0.001) and atherosclerotic plaque occurrence (p < 0.001) were increased in diabetic compared to nondiabetic ESRD patients. Hs-CRP levels were increased and ADP levels were decreased in diabetic compared to nondiabetic ESRD patients (both p < 0.001). ADP levels correlated inversely with hs-CRP (r=-0.473, p < 0.0001) in ESRD patients. Hs-CRP was positively correlated with LVMI (r = 0.365, p < 0.0001), PWVr (r = 0.42, p < 0.0001) and CCA-IMT (r = 0.18, p, = 0.047) while ADP inversely correlated with PWVr (r = -0.263, p = 0.0035) and CCA-IMT (r = -0.207, p = 0.022) in ESRD patients. Conclusion: The present results indicate diabetic disease-specific alterations in the biochemical parameters of hs-CRP and ADP in ESRD patients. The above biochemical parameters were intimately linked to the cardiovascular measurements of LVMI, PWVr and CCA-IMT in patients with ESRD and co-morbid diabetes mellitus. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:340 / 347
页数:8
相关论文
共 50 条
  • [41] Oxidative Balance Score and the Risk of End-Stage Renal Disease and Cardiovascular Disease
    Ilori, Titilayo O.
    Wang, Xiao
    Huang, Morong
    Gutierrez, Orlando M.
    Narayan, K. M. Venkat
    Goodman, Michael
    McClellan, William
    Plantinga, Laura
    Ojo, Akinlolu O.
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 45 (04) : 338 - 345
  • [42] Increase in prevalence of diabetes mellitus as a cause of diallytic end-stage renal disease - Analysis of 20 years in the west region of Parana
    Peres, Luis A. B.
    Matsuo, Tim
    Delfino, ViNicius D. A.
    de Almeida Netto, Jose Henrique
    Ann, Hi K.
    Camargo, Mauricio T. A.
    Rohde, Noris R. S.
    Uscocovich, Vanessa F. M.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2007, 51 (01) : 111 - 115
  • [43] PLASMA 1,5-ANHYDROGLUCITOL CONCENTRATION IN PATIENTS WITH END-STAGE RENAL-DISEASE WITH AND WITHOUT DIABETES-MELLITUS
    EMOTO, M
    TABATA, T
    INOUE, T
    NISHIZAWA, Y
    MORII, H
    NEPHRON, 1992, 61 (02): : 181 - 186
  • [44] EPIDEMIOLOGY OF END-STAGE RENAL-DISEASE IN PATIENTS WITH DIABETES-MELLITUS - FROM THE DARK AGES TO THE MIDDLE-AGES
    CATALANO, C
    MARSHALL, SM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (03) : 181 - 190
  • [45] Arterial pressure components and cardiovascular risk in end-stage renal disease
    Zoccali, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (02) : 249 - 252
  • [46] Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients
    Buraczynska, Monika
    Zaluska, Wojciech
    Buraczynska, Kinga
    Markowska-Gosik, Dorota
    Ksiazek, Andrzej
    HUMAN IMMUNOLOGY, 2015, 76 (11) : 843 - 848
  • [47] Assessment of the incidence rate of end-stage renal disease in patients with and without diabetes in Poland
    Wierzba, Waldemar
    Karnafel, Waldemar
    Tyszko, Piotr
    Kanecki, Krzysztof
    Sliwczynski, Andrzej
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2018, 25 (03) : 568 - 571
  • [48] The metabolic effects of troglitazone in patients with diabetes and end-stage renal disease
    Mohideen, P
    Bornemann, M
    Sugihara, J
    Genadio, V
    Sugihara, V
    Arakaki, R
    ENDOCRINE, 2005, 28 (02) : 181 - 186
  • [49] Epidemiology of end-stage renal disease
    Roderick, P
    CLINICAL MEDICINE, 2002, 2 (03) : 200 - 204
  • [50] Pregnancy and End-Stage Renal Disease
    Tangren, Jessica
    Nadel, Molly
    Hladunewich, Michelle A.
    BLOOD PURIFICATION, 2018, 45 (1-3) : 194 - 200